Although anti–PD-1 monotherapy showed a trend toward reduced melanoma growth without reaching statistical significance, its combination with αCD16-Ova reduced tumor growth by more than 85% and surpassed the effect of αCD16-Ova alone ( Fig. 5A and B ).
← all excerpts
Neutrophil Antigen Presentation Reprograms the Tumor Microenvironment and Elicits Durable and Broad Antitumor Immunity.
1
—
—